| Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 375.66 mm | 375.66 mm | 375.66 mm | 375.66 mm | 375.66 mm | 375.66 mm |
| Cash burn (monthly) | (no burn) | (no burn) | 14.37 mm | 9.04 mm | 8.42 mm | 6.70 mm |
| Cash used (since last report) | n/a | n/a | 61.20 mm | 38.52 mm | 35.88 mm | 28.56 mm |
| Cash remaining | n/a | n/a | 314.45 mm | 337.13 mm | 339.78 mm | 347.10 mm |
| Runway (months of cash) | n/a | n/a | 21.9 | 37.3 | 40.3 | 51.8 |
| 13F holders | Current |
|---|---|
| Total holders | 112 |
| Opened positions | 20 |
| Closed positions | 20 |
| Increased positions | 52 |
| Reduced positions | 22 |
| 13F shares | Current |
|---|---|
| Total value | 2.95 tn |
| Total shares | 83.86 mm |
| Total puts | 33.50 k |
| Total calls | 49.70 k |
| Total put/call ratio | 0.7 |
| Largest owners | Shares | Value |
|---|---|---|
| Biotechnology Value Fund L P | 21.75 mm | $1.05 bn |
| BVF | 21.75 mm | $1.10 tn |
| Cormorant Asset Management | 8.49 mm | $428.28 bn |
| FMR | 4.95 mm | $249.59 bn |
| T. Rowe Price | 2.98 mm | $150.26 mm |
| Avoro Capital Advisors | 2.77 mm | $139.67 bn |
| Citadel Advisors | 2.32 mm | $117.12 bn |
| Holocene Advisors | 1.59 mm | $79.92 bn |
| GS The Goldman Sachs Group, Inc. | 1.50 mm | $75.42 bn |
| Westfield Capital Management | 1.17 mm | $58.86 bn |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 20 Jan 25 | Kristian Reich | Sale back to company | Dispose D | No | No | 0 | 111,949 | 0.00 | 84,367 | |
| 20 Jan 25 | Kristian Reich | Class A ordinary shares, par value $0.0001 per share | Conversion | Acquire C | No | No | 0 | 111,949 | 0.00 | 153,930 |
| 20 Jan 25 | Kristian Reich | Class A ordinary shares, par value $0.0001 per share | Conversion | Dispose C | No | No | 0 | 3,328 | 0.00 | 2,508 |
| 4 Oct 24 | Simon Sturge | Class A ordinary shares, par value $0.0001 per share | Sell | Dispose S | No | No | 53.72 | 171,000 | 9.19 mm | 171,980 |
| 4 Oct 24 | Partners L P/il BVF | Class A Ordinary Shares, $0.0001 par value | Sell | Dispose S | No | No | 50.0016 | 132,549 | 6.63 mm | 1,287,768 |
| 4 Oct 24 | Partners L P/il BVF | Class A Ordinary Shares, $0.0001 par value | Sell | Dispose S | No | No | 50.0016 | 836,862 | 41.84 mm | 8,168,838 |
| 4 Oct 24 | Partners L P/il BVF | Class A Ordinary Shares, $0.0001 par value | Sell | Dispose S | No | No | 50.0016 | 1,030,589 | 51.53 mm | 10,235,089 |
| 6 Jun 24 | Spike Loy | Option to Buy Class A ordinary shares, par value $0.0001 per share | Grant | Acquire A | No | No | 42.44 | 7,688 | 326.28 k | 7,688 |
| 6 Jun 24 | Ramnik Xavier | Option to Buy Class A ordinary shares, par value $0.0001 per share | Grant | Acquire A | No | No | 42.44 | 7,688 | 326.28 k | 7,688 |
